Detalles de la búsqueda
1.
Efficacy and safety of lurbinectedin and doxorubicin in relapsed small cell lung cancer. Results from an expansion cohort of a phase I study.
Invest New Drugs
; 39(5): 1275-1283, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33704620
2.
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial.
Lancet Respir Med
; 11(1): 74-86, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36252599
3.
Antitumor activity of lurbinectedin in second-line small cell lung cancer patients who are candidates for re-challenge with the first-line treatment.
Lung Cancer
; 150: 90-96, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33096421
Resultados
1 -
3
de 3
1
Próxima >
>>